Correction to Lancet Diabetes Endocrinol 2015; published online Nov 24. http://dx.doi.org/10.1016/S2213-8587(15)00417-9
- PMID: 29471920
- DOI: 10.1016/S2213-8587(15)00467-2
Correction to Lancet Diabetes Endocrinol 2015; published online Nov 24. http://dx.doi.org/10.1016/S2213-8587(15)00417-9
Erratum for
-
Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study.Lancet Diabetes Endocrinol. 2016 Mar;4(3):211-220. doi: 10.1016/S2213-8587(15)00417-9. Epub 2015 Nov 27. Lancet Diabetes Endocrinol. 2016. PMID: 26620248 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
